Samsung BioLogics (207940 KS): Korea FSC Ruling Summary & Clarifications

828 Views13 Jul 2018 01:56

This Korea FSC's final ruling on Samsung Biologics Co., Ltd (207940 KS)'s accounting fraud case is very confusing. So, let me walk you...

SUMMARY

(Sign Up to Access)

Try Now

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

SMARTKARMA PREVIEW PASS

By signing up, you agree to our
Terms of Use and Privacy Policy.

Already have an account? Sign In Now

Full Insight

(Paid Plans Only, 5-minute read)

Discussions

(Paid Plans Only)

Top 5%

Korea / Special Sits, Pairs, Index Rebalancing

Clepsydra Capital

South KoreaEvent-DrivenEquity Bottom-Up

Price Chart(Sign Up to Access)

Insight Stream